42 Post-translational Modifications (PTMs), chemical or proteinaceous covalent alterations to 43 the side chains of amino acid residues in proteins, are a rapidly expanding feature class of 44 significant importance in cell biology. Due to a high burden of experimental proof and the lack of 45 effective means for experimentalists to prioritize PTMs by functional significance, currently less 46 than ~2% of all PTMs have an assigned biological function. Here, we describe a new artificial 47 neural network model, SAPH-ire TFx for the functional prediction of experimentally observed 48 eukaryotic PTMs. Unlike previous functional PTM prioritization models, SAPH-ire TFx is optimized 49 with both receiver operating characteristic (ROC) and recall metrics that maximally capture the 50 range of diverse feature sets comprising the functional modified eukaryotic proteome. The tool 51 was through systematic evaluation of input features, model architectures, training procedures, 52 and interpretation metrics using a 2018 training dataset of 430,750 PTMs containing 7,480 PTMs 53 with literature-supported evidence of biological function. The resulting model was used to classify 54 an expanded 2019 dataset of 512,015 PTMs (12,867 known functional) containing 102,475 PTMs 55 unencountered in the original dataset. Model output from the 2019 extended dataset was 56 benchmarked against pre-existing prediction models, revealing superior performance in 57 classification of functional and/or disease-linked PTM sites. Finally, a dynamic web interface 58 provides customizable graphical and tabular visualization of PTM and SAPH-ire TFx data within 59 the context of all modifications within a protein family, exposing several metrics by which important 60 functional PTMs can be identified for investigation. 61 62 63 64 AUTHOR SUMMARY 65
Post-translational modifications (PTMs) alter the chemistry of amino acid residues within 82 translated proteins and thereby have the potential to expand the function and regulatory control 83 of proteins beyond the limits of the genome (1). By definition PTMs modify the structure of 84 proteins, and can consequently alter their function through changes in biomolecular interactions, 85 protein localization and/or protein stability (2,3). PTMs can act on long or short timescales that 86 allow for dynamic control and response of a cellular proteome to changing environments or 87 cellular phases that ultimately shape cellular phenotype (4). Concomitantly, disruption to either 88 the amino acid or modification of highly functional PTM sites can lead to cellular dysfunction and 89 disease (5-7). 90
Since the advent of high-throughput protein sequencing by mass spectrometry, hundreds 91 of different types of PTM have been found to occur on the sidechains of most of the 20 amino 92 acids (8, 9) . However, the rate at which PTM data are generated -a parallel process involving 93 hundreds of independent labs -far surpasses the rate at which it is being curated and/or 94 processed for interpretation -a task undertaken by a much smaller set of labs and institutions 95 (10,11). Today, somewhere between 700K to 1M PTMs represented by nearly 300 unique types 96 are, more or less, accessible in the public domain. Although, such estimates change drastically 97 every year as a result of new technologies that improve detection of any one PTM in the proteome 98 (12). Of these, ~116,000 correspond to human phosphorylation sites -representing about half of 99 the number of phosphosites estimated for the human proteome (13). Thus, the total number of 100 curated PTMs is likely an underestimate of PTMs that exist in the collective eukaryotic proteome. 101
With the exponential increase in PTM data over the last 15 years, a major question is 102 whether all PTMs detected (accurately) are functionally important -a question not easily 103 answered due to the extremely high burden of experimental proof needed to prove functionality, 104 which involves significant time, cost, and specific expertise for any given protein. This is 105 compounded by unnecessary redundancy in experimental effort, and the tendency of most labs 106 not to report non-functional results, and the longstanding and widely accepted premise that not 107 all PTMs are functionally equivalent. Indeed, this underlying dilemma tends to promote a 108 perspective that the study of PTMs is risky and quite possibly not worth the effort, especially in 109 light of the exponential increase in data content that can appear overwhelming to a protein 110 experimentalist. PTM site features such as evolutionary conservation (14-16), PTM co-111 localization (17-19), protein structural constraints (20,21), and other single features, have been 112
shown to be mildly predictive for function and offer useful means of filtering PTM data for likely 113 important modifications. More recently, machine learning models that incorporate multiple single 114 features have been proven to have significantly greater predictive power in comparison to single 115 features alone (22-24). In general, these models provide a priority score that is effective for rank 116 ordering PTM function potential, and are shown to be successful in identifying new functional 117
PTMs across the eukaryotic proteome, but unfortunately do little to confidently recommend PTMs 118 for experimental analysis due to very poor recall of true positive data. 119
Here we describe the development and application of a neural network model, SAPH-ire 120 TFx, optimized for the recommendation of functional PTMs in whole sequence protein families. 121
We used this model to prioritize the potential for function for 512,015 unique PTMs (8,373 known 122 functional) across 38,231 proteins and 763 organisms. This is the first model of its type in which 123 recall has been used for optimization, and we show that this results in significantly improved 124 predictive properties compared to previous versions of SAPH-ire and other functional prioritization 125 SAPH-ire is PTM agnostic and includes 56 different PTM types (PTMtype), the bulk of 133 which correspond to phosphorylation, ubiquitination, acetylation, methylation, N-linked 134 glycosylation, and sumoylation (Table S1 ). PTMs were collected from multiple sources including 135 PhosphositePlus (25), SysPTM (26), and dbPTM (27). Each PTM was mapped to UniProt 136 identifiers (UID) and validated by matching the native position (NP) and residue (res) of the 137 curated PTM to UniProt sequences verified for 100% sequence identity using BLAST (28). 138
Isoforms, although rare in the PTM dataset, were also included. The final PTM dataset contains 139 629,740 unique PTMs (identified by UID-NP-res-PTMtype). 140 UID entries were mapped to whole sequence protein families using InterPro (29) followed 141 by multiple sequence alignment of family-linked UniProt sequences using MUSCLE with default 142 parameters (30). Families with fewer than 2 members containing at least 1 PTM per member were 143 excluded. This process resulted in a final 512,015 PTMs mapped to 8,039 families (Table S2 ) 144 containing 38,231 UIDs representing 763 eukaryotic organisms (Table S3) . to family alignment positions that harbor at least one PTM, as described previously in detail 149 (20,22,23). A total of eleven features are extracted from 319,981 MAPs (containing the 512,015 150 PTMs) for inclusion in neural network models described below ( Table S4) Web interface, which also pulls from the API as its data source, was built in Vue.js relying on 205
Vuetify for design elements and the open source Plotly.js library for delivering graphical summary 206 of the data. 207
RESULTS 209
Optimizing SAPH-ire TFx model architecture and performance through recall 210
Previous models (including our own) have employed the use of quantitative features in 211 isolation (15,16) or in combination (20,22-24,36)) to rank PTMs according to potential for function. 212
In the process of re-evaluating this approach, we concluded that rank-based models are 213 incongruous with functional evidence from biological data, wherein functional impact is broadly 214 defined and highly variable. In contrast, recommendation-based models, in which groups of 215 objects that fit some criteria without asserting any specific entity within that group is a better fit for 216 that criteria than any other, more accurately reflects the intended goal of PTM prioritization - were stochastically trained and evaluated by Fzero and Recall and then filtered to identify the 227 most consistently high performing architectures (Batch 1). The agreement between most of the 228 models made collective intelligence approaches redundant. Therefore, an additional series of 229 models trained with an added feature (family-weighted observation source count) was generated 230 (Batch 2). In general, both batches varied only slightly in terms of ROC AUC (0.68 -0.73), but 231 varied dramatically in recall (0.5 -0.8), suggesting that significant gains in model performance 232
were achieved by considering recall in addition to ROC AUC ( Figure 1B) . The top performing 233 models from these two independent evaluations were averaged together to represent the final 234 SAPH-ire score that outperformed either top model alone (Figure 1B which serves as a proxy for confidence in the assignment of known function status (Figure 2C) . 261
This analysis revealed that SAPH-ire scored PTMs with greater KFSC values significantly higher 262 (p<0.0001) than those with lower KFSC (3+ref/2ref; 2ref/1ref, and 1ref/0refs). This trend was also evident for the 3,233 "New" PTMs of known functional status in the expanded dataset to which 264 algorithm was completely blind during initial training (Figure 2C , dashed lines). Taken together, 265 these data show that SAPH-ire TFx is an effective recommendation model for functional PTMs 266 and is robust in its performance across independent datasets. 
Biological Significance 281
We hypothesized that MAPs containing sites of PTM that coincide with a known 282 pathogenic mutation should have higher SAPH-ire scores than those that are benign when 283 silenced, if the model can recommend functionally significant PTMs. To test this hypothesis, we 284 compared the SAPH-ire TFx scores of PTMs whose sites correspond to mis-sense mutations 285 curated in the ClinVar disease linkage database (34). We observed significantly higher scores 286 (p=0.0003) for PTMs coincident with pathogenic mutations (median score = 0.475) compared to 287 benign mutations (median score = 0.033) (Figure 3) . As expected from the sigmoid response 288 curve of the SAPH-ire model, the score distributions exhibit two regions of enrichment. The first 289 region encompasses PTMs with a score less than .05, in which there is a slightly greater 290 enrichment (37%) for benign versus pathogenic mutations. The second region represents the top 291 10% of PTMs by SAPH-ire TFx score (score above .95), and above this threshold there is 292 significant overrepresentation (156%) of pathogenic compared to benign mutations. The 293 enrichment of high scoring pathogenic-SNP-coincident PTMs follows with the corollary that if the 294 model is capable of distinguishing between PTMs with and without functional impact, then MAPs 295 that coincide with disease-causing SNPs should be overrepresented compared to benign SNPs 296 as the SAPH-ire score increases. However, it's also important to note that there are also several 297 SNP/PTM sites for which the model does not support this corollary. This seeming incongruity, can 298 be readily explained as not every SNP labeled as pathogenic is necessarily dependent on the 299 effect of lost PTM. Alternatively, PTMs coincident with SNP mutations that are labelled benign 300 could still have functional significance but not be pathogenic when silenced. 
Recommendation thresholding is essential for model interpretation 309
Thresholding is an essential component of a recommendation model that provides a useful 310 filter for large datasets. Prior models for the functional prioritization of PTMs, while providing 311 quantitative distributions of potential function, have largely struggled to provide well-defined 312 thresholds that support confident recommendations for further investigation. To address this 313 problem, we modeled the tradeoff between true and false positive rates using ROC curves. Our 314 goal was to set a minimum threshold score over which MAPs could be considered having a high 315 chance of functionality. Due to our desire for SAPH-ire scores to be agnostic across different PTM 316 types, we first considered that the selected thresholds must not create a bias in distribution of 317
PTMs occurring above that threshold. To evaluate this, we plotted the percent representation of 318 each of the most common PTMs in the dataset relative to SAPH-ire TFx score (Figure 4A) . The 319 relative representation of each PTM type deflected significantly above a score of 0.9897 but was 320 stable below this point and above 0.945, the range between which we defined as ideal for 321
thresholding. 322
Next, we evaluated the ROC curves for the highest confidence true positive MAPs (KFSC 323 >1, >2) ( Figure S1) , and unfurled each curve to reveal the independent rates for true and false 324 positives with respect to the SAPH-ire TFx score. From these curves, three thresholds were 325 chosen within the ideal range (0.95, 0.9719, and 0.987) that strike a balance between true positive 326 hits and false positive recommendations (Figure 4B) . These recommendation thresholds provide 327 useful landmarks to interpret SAPH-ire TFx scores for a protein or family of interest, as shown 328 here for family IPR000043 (Figure 4C) . They also serve as benchmarks for evaluating other 329 models and future versions of SAPH-ire. ire TFx plot for family IPR000043 (Adenosylhomocysteinase-like family) with indicated thresholds 339
shown for reference. Shown on an exponential scale to emphasize rank distribution. 340 341
Comparison to other models 342
SAPH-ire TFx is a unique model that is one of a small number of published algorithms 343 aimed at functional prioritization of PTMs, and also the first recommendation model for functional 344
PTMs. We therefore sought to draw comparisons with these models to gauge overall In general, SAPH-ire FPx and PFS perform similarly in most respects -in part because 380 they were both built to maximize ROC AUC but not recall. Both models result in broad and 381 overlapping score distributions that are significantly different but modestly distinct between sites 382 of known and unknown function (Figure 5B) . This results from broad score distributions that 383 change marginally across bins of increasing KFSC. SAPH-ire FPx tends to have lower average 384 scores that are compressed for the unknown function category and don't increase dramatically 385 until reaching KFSC >2 true positive status. PFS exhibits higher overall scores compared to 386
SAPH-ire FPx but shows comparable responsiveness to increasing KFSC. The score distribution 387 of the two models as shown by inter-quartile range also increases by almost 2-fold with increasing 388 KFSC, which is counter to the expectation for increased confidence in classification (Figure 5C) . 389
Consequently, the recommendation thresholds used for each model must be low to enable either 390 model to capture even a small percentage of true positive phosphosites. A separate analysis 391 comparing only PFS and SAPH-ire TFx, which includes a larger phosphosite overlap (49,935 392 phosphosites), showed similar results (Figure S3) . 393
In contrast to SAPH-ire FPx and PFS, the score distributions for SAPH-ire TFx become 394 less, rather than more broad with increasing KFSC, concomitant with the expectation for greater 395 confidence with increasing score (Figure 5B,C) . ROC and recall curves for all three models show 396 that this difference is largely due to improved recall performance of SAPH-ire TFx, while ROC 397 AUC is otherwise similar between the three different models (Figure 5D) . The practical 398 consequences of the differences between SAPH-ire TFx and other models is evident in terms of 399 number of missed calls based on recommended thresholds, where as many as 32% of highly 400 confident true positive functional PTMs (KFSCMAP > 2) are mis-called by previous models -a 401 quantity that is lowered to less than 6% in SAPH-ire TFx (Figure 5E ). This also results in an 402 increase in the number of phosphosites recommended as functionally impactful at all thresholds 403
(see Conclusions). 404
We next compared all three models to a recently published fourth model that is not based 405 on machine learning, but rather on a derivative of sequence homology modeling (37). In brief, this 406 method calls conserved phosphorylation hotspots that are defined based on the sequence 407 conservation of protein regions in domain families that are densely populated with observed 408 phosphorylation sites. In general, high scores were enriched for conserved phosphosite hotspots 409 regardless of model, with SAPH-re TFx exhibiting the best overall performance in terms of recall 410 and score distribution across KFSC (Figure S3) . Taken together, these data strongly support the 411 conclusion that SAPH-ire TFx is a robust and effective model for the classification of PTM function, 412
which surpasses the performance of previous models. 413
SAPH-ire web interface 415
To support the community with easy access to SAPH-ire TFx, we have launched a web 416 resource (https://saphire.biosci.gatech.edu). This resource provides an intuitive and dynamic 417 interface for interacting with SAPH-ire predictions and allows for quick prioritization of PTMs of 418 interests in context of either a protein or family of interest. In the results window for the tool, one 419 can quickly retrieve and analyze the SAPH-ire scores and general statistics for the associated 420
PTMs, as well as quickly identify known functional PTMs in the family (Figure 6) . Additionally, 421 SAPH-ire predictions are made available via API. and tabular display that can be filter-updated by the user and downloaded to produce figures. 426
Tabular data is searchable and is color coordinated to indicate PTMs aligned with or 427 correspondent with known functional data, including PubMed reference IDs, hyperlinks to protein 428 (UniProt) or protein family (InterPro) information, among other features. Additionally, information 429
is machine accessible through a corresponding API provided at the same domain. 430 431
DISCUSSION 432
Using systematic architecture and training optimization procedures we have created a new 433 machine learning model and complimentary web-accessible tool -SAPH-ire TFx -that is capable 434 of confidently recommending PTMs of likely functional significance. To our knowledge, this is the 435 first recommendation tool that does not rely solely on probability-based ranking for functional 436 prioritization. As estimated by ROC and recall analyses, the model is shown to be highly predictive 437 for recall of PTMs of known function, and this property is enhanced at increasing score thresholds 438 provided by the model. After its development, we tested the model with an expanded dataset to 439 which it had never been previously exposed, showing that its performance characteristics are 440 robust. To estimate its performance with physiologically relevant predictions, we demonstrated 441 that the model enriches PTMs that are coincident with pathogenic point mutations significantly 442 over those coinciding with benign mutations -an expected trend for models that predict the 443 functional importance of protein residues. In a series of benchmarking tests, we further showed 444 that SAPH-ire TFx outperforms existing machine learning or conservation-based hotspot models 445 (including one of our previous models) in all respects, including ROC, recall, and prediction 446 confidence. Finally, we provide quantitatively-validated thresholds that maximize confidence, 447 recall, and recommendations of unknown function PTMs (the ultimate goal of the model). All 448 model output is provided in a user-accessible web interface that is intended to maximize 449 knowledge about any given PTM in the context of all PTMs for a protein and/or protein family. 450
An important consideration in the design and interpretation of any model intended to 451 predict whether a PTM is functionally significant is the absence of true negative data -i.e. PTMs 452 for which definitive evidence demonstrates that they have no biological impact. This inevitable 453 characteristic of PTM data prohibits the estimation of accuracy as an evaluation metric and forces 454 reliance on true positive data alone as an evaluation metric. Our current perspective is that models 455 failing to efficiently capture true positive data fail to recognize the combinations of protein features 456 underlying the breadth of PTM functions that are known to exist in the eukaryotic proteome. 457 SAPH-ire TFx is the first model for the prediction of functional PTMs that maximizes the recall of 458 true positive data and so hopefully minimizes this concern as much as possible. As we have 459
shown here, models that do not optimize recall suffer from broad score distributions that force 460 extremely conservative thresholding to capture a reasonable (albeit small) fraction of true positive 461 data (Figure 5E) . The accumulation of additional experimental data over time will certainly 462 highlight the robustness of these and future models. 463
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